dc.contributor.author | Garrido, P | |
dc.contributor.author | Adjei, AA | |
dc.contributor.author | Bajpai, J | |
dc.contributor.author | Banerjee, S | |
dc.contributor.author | Berghoff, AS | |
dc.contributor.author | Choo, SP | |
dc.contributor.author | Felip, E | |
dc.contributor.author | Furness, AJS | |
dc.contributor.author | Garralda, E | |
dc.contributor.author | Haanen, J | |
dc.contributor.author | Letsch, A | |
dc.contributor.author | Linardou, H | |
dc.contributor.author | Peters, S | |
dc.contributor.author | Sessa, C | |
dc.contributor.author | Tabernero, J | |
dc.contributor.author | Tsang, J | |
dc.contributor.author | Yang, JC-H | |
dc.contributor.author | Garassino, MC | |
dc.date.accessioned | 2021-08-12T13:09:25Z | |
dc.date.available | 2021-08-12T13:09:25Z | |
dc.date.issued | 2021-06-16 | |
dc.identifier.citation | ESMO open, 2021, 6 (3), pp. 100131 - ? | |
dc.identifier.issn | 2059-7029 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4756 | |
dc.identifier.eissn | 2059-7029 | |
dc.identifier.doi | 10.1016/j.esmoop.2021.100131 | |
dc.description.abstract | BACKGROUND: European Society for Medical Oncology Women for Oncology (ESMO W4O) research has previously shown under-representation of female oncologists in leadership roles. As early reports suggested disproportionate effects of the COVID-19 pandemic on women, the ESMO W4O Committee initiated a study on the impact of the pandemic on the lives of female and male oncologists. METHODS: A questionnaire was sent to ESMO members and put on the ESMO website between 8 June 2020 and 2 July 2020. Questions focused on the working (hospital tasks, laboratory tasks, science) and home (household management, childcare, parent care, personal care) lives of oncologists during and after COVID-19-related lockdowns. RESULTS: Of 649 respondents, 541 completed the questionnaire. Of these, 58% reported that COVID-19 had affected their professional career, 83% of whom said this was in a negative way (85% of women versus 76% of men). Approximately 86% reported that COVID-19 had changed their personal life and 82% their family life. Women were again significantly more affected than men: personal life (89% versus 78%; P = 0.001); family life (84% versus 77%; P = 0.037). During lockdowns, women reported increased time spent on hospital and laboratory tasks compared with men (53% versus 46% and 33% versus 26%, respectively) and a significantly higher proportion of women than men spent less time on science (39% versus 25%) and personal care (58% versus 39%). After confinement, this trend remained for science (42% versus 23%) and personal care (55% versus 36%). CONCLUSIONS: The COVID-19 pandemic has adversely affected the professional and home lives of oncologists, especially women. Reduced research time for female oncologists may have long-lasting career consequences, especially for those at key stages in their career. The gender gap for promotion to leadership positions may widen further as a result of the pandemic. | |
dc.format | Print-Electronic | |
dc.format.extent | 100131 - ? | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
dc.subject | Humans | |
dc.subject | Medical Oncology | |
dc.subject | Communicable Disease Control | |
dc.subject | Adult | |
dc.subject | Middle Aged | |
dc.subject | Female | |
dc.subject | Male | |
dc.subject | Young Adult | |
dc.subject | Pandemics | |
dc.subject | Surveys and Questionnaires | |
dc.subject | Oncologists | |
dc.subject | COVID-19 | |
dc.subject | SARS-CoV-2 | |
dc.title | Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2021-04-04 | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1016/j.esmoop.2021.100131 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | ESMO open | |
pubs.issue | 3 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/ImmNet | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/ImmNet | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 6 | |
pubs.embargo.terms | Not known | |
dc.contributor.icrauthor | Furness, Andrew | |